|
|
Article: Research and Markets: Currently Druggable in Melanoma: a Drug Target Competitive Analysis Reports on 94 Unique Drug Target Combinations.
- Article from:
- Business Wire
- Article date:
- October 16, 2008
CopyrightCOPYRIGHT 2008 Business Wire. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/research/ddbcf1/currently_druggabl) has announced the addition of the "Currently Druggable in Melanoma: A Drug Target Competitive Analysis" report to their offering.
This report aims to analyze the current and future potential of melanoma pipeline by examining key fundamentals across the entire pipeline of drug candidates. The author has identified three fundamental dimensions to outline the competitive landscape within the pharmaceutical industry; compound type, therapy area and target type.
This report is written for you to identify your competition and understand which ...